Literature DB >> 22024091

Predictive value of serum CEA, CA19-9 and CA72.4 in early diagnosis of recurrence after radical resection of gastric cancer.

Yan Li1, Ying Yang, Ming Lu, Lin Shen.   

Abstract

BACKGROUND/AIMS: To explore the predictive value of markers in detection of recurrence after resection.
METHODOLOGY: This study was a case-control retrospective analysis; 521 patients underwent radical gastrectomy from April 2000 to January 2008, among whom 142 cases with complete data were involved. Seventy one were confirmed with recurrence, while the other 71 without recurrence were randomly selected from the database as control. We analyzed the popular serum marker change patterns and their correlation with imaging.
RESULTS: The two groups were well balanced in characteristics. Among the 3 markers, CA72.4 appeared highest in sensitivity (35.2%) while CEA had the lowest sensitivity. The sensitivity of triple-marker was 62.0%. We found that CEA, CA19-9 and CA72.4 elevated 2-4 months before imaging demonstration. If the cut-off values of CEA and CA19-9 were set twice as the upper limit of the normal, the specificities will increase to 98.6% and 94.4%, respectively. The sensitivity of single marker (CEA or CA 2.4) was 33.3% in predicting peritoneal metastasis, triple-marker had the highest sensitivity (66.7%).
CONCLUSIONS: The combined of CEA, CA19-9 and CA72.4 had 62.0% sensitivity in the diagnosis of recurrence after radical surgery. Patients whose tumor markers continue to increase should be highly suspected for relapse.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22024091     DOI: 10.5754/hge11753

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  33 in total

1.  PIAS3, an inhibitor of STAT3, has intensively negative association with the survival of gastric cancer.

Authors:  Jingwu Li; Jianzhong Cui; Jinghua Zhang; Yuanting Liu; Longcai Han; Chunliang Jia; Jingyu Deng; Han Liang
Journal:  Int J Clin Exp Med       Date:  2015-01-15

2.  Overexpression of HOXB7 is associated with a poor prognosis in patients with gastric cancer.

Authors:  Weiwei Tu; Xingwu Zhu; Yang Han; Yugang Wen; Guoqiang Qiu; Chongzhi Zhou
Journal:  Oncol Lett       Date:  2015-08-25       Impact factor: 2.967

3.  Methylated CpG site count of dapper homolog 1 (DACT1) promoter prediction the poor survival of gastric cancer.

Authors:  Jingyu Deng; Han Liang; Rupeng Zhang; Guoguang Ying; Xingmin Xie; Jun Yu; Daiming Fan; Xishan Hao
Journal:  Am J Cancer Res       Date:  2014-09-06       Impact factor: 6.166

4.  Quantitative comparisons of summary receiver operating characteristics (sROC) curves among conventional serological tumor biomarkers for predicting gastric cancer in Chinese population.

Authors:  Xin-Zu Chen; Wei-Han Zhang; Kun Yang; Bo Zhang; Zhi-Xin Chen; Jia-Ping Chen; Zong-Guang Zhou; Jian-Kun Hu
Journal:  Tumour Biol       Date:  2014-06-07

5.  Monitoring of peri-distal gastrectomy carbohydrate antigen 19-9 level in gastric juice and its significance.

Authors:  A-Man Xu; Lei Huang; Wen-Xiu Han; Zhi-Jian Wei
Journal:  Int J Clin Exp Med       Date:  2014-01-15

6.  Detection of perioperative cancer antigen 72-4 in gastric juice pre- and post-distal gastrectomy and its significances.

Authors:  Lei Huang; Aman Xu; Tuanjie Li; Wenxiu Han; Shanshan Wu; Yangyi Wang
Journal:  Med Oncol       Date:  2013-07-03       Impact factor: 3.064

Review 7.  Potential prognostic, diagnostic and therapeutic markers for human gastric cancer.

Authors:  Ming-Ming Tsai; Chia-Siu Wang; Chung-Ying Tsai; Hsiang-Cheng Chi; Yi-Hsin Tseng; Kwang-Huei Lin
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

8.  Identification of Serum Biomarkers for Gastric Cancer Diagnosis Using a Human Proteome Microarray.

Authors:  Lina Yang; Jingfang Wang; Jianfang Li; Hainan Zhang; Shujuan Guo; Min Yan; Zhenggang Zhu; Bin Lan; Youcheng Ding; Ming Xu; Wei Li; Xiaonian Gu; Chong Qi; Heng Zhu; Zhifeng Shao; Bingya Liu; Sheng-Ce Tao
Journal:  Mol Cell Proteomics       Date:  2015-11-23       Impact factor: 5.911

9.  Evaluation of the Role of Circulating Long Non-Coding RNA H19 as a Promising Novel Biomarker in Plasma of Patients with Gastric Cancer.

Authors:  Doaa Hashad; Amany Elbanna; Abeer Ibrahim; Gihan Khedr
Journal:  J Clin Lab Anal       Date:  2016-05-17       Impact factor: 2.352

Review 10.  Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association.

Authors:  Hideaki Shimada; Tamaki Noie; Manabu Ohashi; Koji Oba; Yutaka Takahashi
Journal:  Gastric Cancer       Date:  2013-04-10       Impact factor: 7.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.